Efavirenz NVP 502

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
600 mg daily
Drug 1 effect

Efavirenz AUC decreased 22%; Cmin decreased 36%

Drug 2
Drug 2 dose
200 mg daily x 2 weeks, then 400 mg daily
Drug 2 effect

No significant change

Clinical Effects

Decreased efavirenz effects

Management

Monitor and adjust therapy as indicated; may consider increasing efavirenz to 800 mg daily

Import ID
502